Home
>
US Stocks
>
VectivBio Holding AG
VectivBio Holding AG
VECT

VectivBio Holding AG

$6.0619.74%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
6.18
Today Low/High
6.06 / 6.18
52 Week Low/High
$7.12 / $37.7
Market Cap
$245.25M

Company Details

VectivBio is a global, clinical-stage biotechnology company focused on the discovery, development and commercialization of innovative treatments for severe rare conditions with high unmet medical need. The company is committed to pursuing product candidates with a clear mechanism of action and the potential to meaningfully transform and improve the lives of patients and their families. VectivBio’s product candidate, apraglutide, is a next-generation GLP-2 analog being developed as a differentiated therapeutic for a range of rare gastrointestinal (GI) diseases. Apraglutide is currently being evaluated in a global phase 3 clinical trial as a once-weekly treatment for short bowel syndrome with intestinal failure (SBS-IF).
Organisation
VectivBio Holding AG

Discover more

Frequently Asked Questions

What is VectivBio Holding AG share price today

Can Indians buy VectivBio Holding AG shares?

How can I buy VectivBio Holding AG shares from India?

Can Fractional shares of VectivBio Holding AG be purchased?

What are the documents required to start investing in VectivBio Holding AG stocks?

We are a SEBI registered investement advisor